A Study of RoActemra/Actemra (Tocilizumab) With or Without Methotrexate in Patients With Mild to Moderate Rheumatoid Arthritis With an Inadequate Response to Methotrexate
Clinical trial NCT01587989 · COMPLETED
Trial details
- NCT number
- NCT01587989
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2014-02-01
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.